Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy - Contacts and Locations

Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy

This study is currently recruiting participants.
Information provided by University Health Network, Toronto

Please refer to this study by its ClinicalTrials.gov identifier: NCT00593853

Contacts


Contact: Kelly M Caetano, BHSc	416-946-4501 ext 3141	kelly.caetano@uhn.on.ca

Contact: Karen Hersey, R.N	416-946-4501 ext 2155	karen.hersey@uhn.on.ca

Locations


Canada, Ontario
	UHN Princess Margaret Hospital	Recruiting
	Toronto, Ontario, Canada, M5G 2M9
	Principal Investigator: Neil E Fleshner, MD

Sponsors and Collaborators

University Health Network, Toronto

Sanofi-Aventis

Investigators


Principal Investigator:	Neil E Fleshner, MD	University Health Network, Toronto

Principal Investigator:	Shabbir MH Alibhai, MD	University Health Network, Toronto